Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Clinical Trial of Simultaneous Administration of Oral Aspirin and Ketamine as Adjunct to Oral Antidepressant Therapy in Treatment-Resistant Depression

NCT05615948 is registered in ClinicalTrials.gov with Theresa Jacob, PhD, MPH as lead sponsor.

NCT NCT05615948
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05615948 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Clinical Trial of Simultaneous Administration of Oral Aspirin and Ketamine as Adjunct to Oral Antidepressant Therapy in Treatment-Resistant Depression
Lead sponsor
Theresa Jacob, PhD, MPH
Phase
Phase 4
Overall status
Completed
Start date
December 6, 2022
Completion date
May 17, 2024
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

analgesia, analgesics, non-narcotic, anti-inflammatory agents, anti-inflammatory agents, non-steroidal, central nervous system depressants, depressive symptoms, ketamine, major depressive disorder, neurotransmitter agents, peripheral nervous system agents, physiological effects of drugs, sensory system agents, treatment resistant depression